StockData
Kardigan, Inc. logo

Kardigan, Inc. (KARD) company profile

KARDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$13.19+0.34 (+2.65%)

Close on Nov 17, 2026Market cap $1.23BP/E –Yield –

About Kardigan

Pharmaceutical Preparations, SIC 2834

Kardigan, Inc. is listed on Nasdaq under the ticker KARD, in the SEC industry Pharmaceutical Preparations. It is incorporated in Delaware and its fiscal year ends on December 31. Reported financials on StockData start in fiscal 2024.

Company profile

Company

Legal name
Kardigan, Inc.
Headquarters
South San Francisco, CA
Address
C/O Kardigan, Inc., 131 Oyster Point Blvd., Second Floor 94080
Phone
(415) 573-3220
Industry
Pharmaceutical Preparations
Incorporated in
Delaware
Fiscal year ends
December 31

Stock & identifiers

Ticker
KARD
Exchange
Nasdaq
IPO date
Jun 18, 2026
Shares outstanding
94M, Aug 7, 2026
Filer category
<br>Emerging growth company
SEC CIK
2123613
CUSIP
48563V117
ISIN
US48563V1171
FIGI
BBG01T3TSSM2
Share class FIGI
BBG01T3TSSN1
EIN
93-2994203

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Anastasios GianakakosPresident & CEO, Director9,806,633
John B. MoriartyChief Legal Officer47,784
Jay EdelbergChief Medical Officer4,595,383
Andy PasternakChief Strategy Officer79,640
Brianne JahnChief Financial Officer79,640
Kristin Marie K. ReinkeDirector–
Advisors Llc PerceptiveDirector–
Capital Solutions Holdings LP PerceptiveDirector–
Joseph EdelmanDirector20,706
Life Sciences Master Fund Ltd PerceptiveDirector–
Kristina BurowDirector–
Paul L. BernsDirector15,062,741
Steven GillisDirector–
ARCH Venture Partners XIII, LLCDirector–
ARCH Venture Fund XIII, L.P.Director–
ARCH Venture Partners XIII, L.P.Director–
Keith CrandellDirector–
Robert NelsenDirector15,042,035
David P. MeekerDirector20,706
Kimberly J. PopovitsDirector20,706
Douglas E. GiordanoDirector20,706
Timothy P. WalbertDirector20,706

IPO

From the final prospectus (Form 424B4) and the first day of trading

Offering

Type
Initial public offering
Final prospectus filed
Jun 18, 2026
Offer price
$16.00
Securities offered
25,000,000
Gross proceeds
$400.00M
Exchange
Nasdaq
First trading day
Jun 18, 2026
First-day close
$22.00+37.5%
Lock-up ends (est.)
Dec 15, 2026

“The initial public offering price per share is $16.00.”

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

Corporate history

Events identified from SEC filings

See a number that looks wrong?